NCT04733924

Efficacy and Tolerability of Sensoril® in Improving Immunity and Thereby Reducing Incidence of Upper Respiratory Tract Infections

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 77 (actual)
• Sponsor: Vedic Lifesciences Pvt. Ltd. · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

to assess the efficacy and safety of a standardized Withania somnifera extract (Sensoril®) as an immunomodulator in individuals suffering from recurrent URTIs. The study population will be administered with this unique blend of WS extract for 12 weeks and will be assessed as per the study designated efficacy and safety variables.

Conditions

• Immune Health

Interventions

Type	Name	Description
OTHER	Aqueous extract of roots plus leaves of Withania somnifera 125 mg	One capsule before breakfast for 84 days
OTHER	Aqueous extract of roots plus leaves of Withania somnifera 250 mg	One capsule before breakfast for 84 days
OTHER	Microcrystalline Cellulose	One capsule before breakfast for 84 days

Timeline

• Start date: 2021-01-21
• Primary completion: 2021-04-29
• Completion: 2021-09-23
• First posted: 2021-02-02
• Last updated: 2021-10-19

Locations

3 sites across 1 country: India